




Chicken or the Egg?
Response to Pillar and Shehadeh
I
read with great interest the article by
Pillar and Shehadeh (1) on the coher-
ences between obstructive sleep apnea
(OSA) syndrome and associated meta-
bolic alterations apparently linked by
obesity.Theauthorsgiveagoodoverview
of the current literature about sleep dis-
turbances in OSA and various aspects re-
lated to the metabolic syndrome,
particularlyobesity,suchasglucoseintol-
erance and insulin resistance. Notwith-
standing, as the authors correctly
mention, the clinical picture of OSA is
characterized by both sleep fragmenta-
tion and recurrent hypoxic periods,
which were somewhat neglected in their
article.
Astheauthorsmentioned,theunder-
lying mechanism of insulin resistance in
OSA is not fully understood. The poten-
tial options presented in the article were
effectivesleepdeprivationassociatedwith
OSA and an additional involvement of el-
evated sympathetic activity. Concerning
the role of hypoxia in this context, merely
one study in an animal model was indi-
cated: Polotsky et al. (2) examined the ef-
fect of intermittent hypoxia on glucose
metabolism in mice, which resulted in
improvements in glucose tolerance. By
contrast, our group (3) clearly demon-
strated in healthy humans that brief peri-
ods of moderate hypoxia, i.e., 30 min of
oxygen desaturation to a level of 75%, are
sufﬁcient to cause glucose intolerance,
which persists for an additional 2 h after
normalization of oxygenation levels de-
spite the fact that sympathetic activation
uponthisinterventionisratherweak(un-
changed blood pressure and moderate
riseinepinephrine)andparametersofthe
hypothalamus-pituitary-adrenal axis
were not affected at all.
Moreover, our study can help to clar-
ify the question raised by Pillar and She-
hadeh of whether OSA worsens obesity.
We found that experimentally induced
hypoxia leads to a persistent suppression
of resting energy expenditure in healthy
subjects (4), an aspect centrally involved
in the development and worsening of
obesity, which is most likely also of rele-
vance for weight gain in OSA.
On the other hand, leptin secretion
was not altered upon short-term hypoxia.
This adipokine is tightly involved in the
endocrine control of energy expenditure
and body weight regulation by sending a
feedback signal to the brain concerning
the size of peripheral fat stores. Although
leptin is predominantly released by sub-
cutaneousandnotbyabdominalfattissue
(5), its role in the development of obesity
is certainly unquestioned. However, the
divergent impact that hypoxia apparently
exertsonglucoseandenergymetabolism,
stress axis activation, and leptin secretion
suggests that OSA-associated alterations
in these parameters are determined by
multifactorial mechanisms, i.e., sleep
fragmentation, hypoxia, and obesity de-
velopment. Thus, as Pillar and Shehadeh
rightly state, the future challenge in elu-
cidating the pathogenesis of OSA and re-
lated metabolic changes will be to clarify:
Which came ﬁrst: the chicken or the egg?
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